These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36357462)

  • 61. Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography.
    Ikuta S; Kobuke K; Iwanaga Y; Nakauchi Y; Yamaji K; Miyazaki S
    Heart Vessels; 2014 May; 29(3):320-7. PubMed ID: 23793881
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
    Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
    Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
    Scott NA
    Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
    Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
    Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In-stent restenosis.
    Kim MS; Dean LS
    Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Efficacy of stents coated with antibody against CD105 on preventing restenosis and thrombosis in minipigs].
    Cui S; Lü SZ; Chen YD; He GX; Yan HB; Meng LJ; Liu H; Song XT; Jin ZN; Ge CJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):648-51. PubMed ID: 21055292
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.
    Nakazawa G; Granada JF; Alviar CL; Tellez A; Kaluza GL; Guilhermier MY; Parker S; Rowland SM; Kolodgie FD; Leon MB; Virmani R
    JACC Cardiovasc Interv; 2010 Jan; 3(1):68-75. PubMed ID: 20129572
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Re-Endothelialization Study on Endovascular Stents Seeded by Endothelial Cells through Up- or Downregulation of VEGF.
    Wu X; Zhao Y; Tang C; Yin T; Du R; Tian J; Huang J; Gregersen H; Wang G
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):7578-89. PubMed ID: 26925508
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The importance of the endothelium in atherothrombosis and coronary stenting.
    Otsuka F; Finn AV; Yazdani SK; Nakano M; Kolodgie FD; Virmani R
    Nat Rev Cardiol; 2012 May; 9(8):439-53. PubMed ID: 22614618
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry.
    Sugihara M; Miura S; Nishikawa H; Ike A; Mori K; Iwata A; Kawamura A; Saku K
    J Cardiol; 2013 Feb; 61(2):117-21. PubMed ID: 23159206
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inflammatory mechanisms of adverse reactions to BMS.
    Toutouzas K; Karanasos A; Stefanadis C
    Curr Vasc Pharmacol; 2013 Jul; 11(4):379-91. PubMed ID: 23905633
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Point-of-care seeding of nitinol stents with blood-derived endothelial cells.
    Jantzen AE; Noviani M; Mills JS; Baker KM; Lin FH; Truskey GA; Achneck HE
    J Biomed Mater Res B Appl Biomater; 2016 Nov; 104(8):1658-1665. PubMed ID: 26340233
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Citric acid functionalized nitinol stent surface promotes endothelial cell healing.
    Ceresnakova M; Murray D; McGourty KD; Butler J; Neilan J; Soulimane T; Hudson SP
    J Biomed Mater Res A; 2021 Sep; 109(9):1549-1559. PubMed ID: 33624931
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.
    Fishbein I; Alferiev IS; Nyanguile O; Gaster R; Vohs JM; Wong GS; Felderman H; Chen IW; Choi H; Wilensky RL; Levy RJ
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):159-64. PubMed ID: 16371477
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preventable effects of bare-metal stent on restenosis after everolimus-eluting stent deployment.
    Shirakabe A; Takano M; Yamamoto M; Kurihara O; Kobayashi N; Matsushita M; Tsurumi M; Okazaki H; Hata N; Shimizu W
    Heart Vessels; 2016 Mar; 31(3):434-7. PubMed ID: 25330762
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bare metal stent implantation for in-stent restenosis with a drug-eluting stent.
    Matsuoka H; Kawakami H; Ohshita A; Kohno T; Shigemi S; Okayama H; Higaki J
    J Cardiol; 2010 Jan; 55(1):135-8. PubMed ID: 20122561
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pathological features of in-stent restenosis after sirolimus-eluting stent versus bare metal stent placement.
    Abe S; Yoneda S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
    Cardiovasc Pathol; 2012; 21(2):e19-22. PubMed ID: 21489821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.